Ersche Karen D, Bullmore Edward T, Craig Kevin J, Shabbir Shaila S, Abbott Sanja, Müller Ulrich, Ooi Cinly, Suckling John, Barnes Anna, Sahakian Barbara J, Merlo-Pich Emilio V, Robbins Trevor W
University of Cambridge, Behavioural and Clinical Neuroscience Institute, Department of Psychiatry, Cambridge, England.
Arch Gen Psychiatry. 2010 Jun;67(6):632-44. doi: 10.1001/archgenpsychiatry.2010.60.
There are no effective pharmacotherapies for stimulant dependence but there are many plausible targets for development of novel therapeutics. We hypothesized that dopamine-related targets are relevant for treatment of stimulant dependence, and there will likely be individual differences in response to dopaminergic challenges.
To measure behavioral and brain functional markers of drug-related attentional bias in stimulant-dependent individuals studied repeatedly after short-term dosing with dopamine D(2)/D(3) receptor antagonist and agonist challenges.
Randomized, double-blind, placebo-controlled, parallel-groups, crossover design using pharmacological functional magnetic resonance imaging.
Clinical research unit (GlaxoSmithKline) and local community in Cambridge, England.
Stimulant-dependent individuals (n = 18) and healthy volunteers (n = 18).
Amisulpride (400 mg), pramipexole dihydrochloride (0.5 mg), or placebo were administered in counterbalanced order at each of 3 repeated testing sessions.
Attentional bias for stimulant-related words was measured during functional magnetic resonance imaging by a drug-word Stroop paradigm; trait impulsivity and compulsivity of dependence were assessed at baseline by questionnaire.
Drug users demonstrated significant attentional bias for drug-related words, which was correlated with greater activation of the left prefrontal and right cerebellar cortex. Attentional bias was greater in people with highly compulsive patterns of stimulant abuse; the effects of dopaminergic challenges on attentional interference and related frontocerebellar activation were different between high- and low-compulsivity subgroups.
Greater attentional bias for and greater prefrontal activation by stimulant-related words constitute a candidate neurocognitive marker for dependence. Individual differences in compulsivity of stimulant dependence had significant effects on attentional bias, its brain functional representation, and its short-term modulation by dopaminergic challenges.
目前尚无治疗兴奋剂依赖的有效药物疗法,但有许多开发新型疗法的合理靶点。我们假设与多巴胺相关的靶点与兴奋剂依赖的治疗相关,并且对多巴胺能刺激的反应可能存在个体差异。
在短期给予多巴胺D(2)/D(3)受体拮抗剂和激动剂刺激后,对兴奋剂依赖个体进行多次研究,测量与药物相关的注意力偏差的行为和脑功能标志物。
采用药理功能磁共振成像的随机、双盲、安慰剂对照、平行组、交叉设计。
临床研究单位(葛兰素史克)和英国剑桥当地社区。
兴奋剂依赖个体(n = 18)和健康志愿者(n = 18)。
在3次重复测试的每一次中,以平衡顺序给予氨磺必利(400 mg)、盐酸普拉克索(0.5 mg)或安慰剂。
在功能磁共振成像期间,通过药物-单词Stroop范式测量对兴奋剂相关单词的注意力偏差;在基线时通过问卷评估依赖的特质冲动性和强迫性。
吸毒者对与药物相关的单词表现出显著的注意力偏差,这与左前额叶和右小脑皮质的更大激活相关。在具有高度强迫性兴奋剂滥用模式的人群中,注意力偏差更大;高强迫性和低强迫性子组之间,多巴胺能刺激对注意力干扰和相关额小脑激活的影响不同。
对兴奋剂相关单词的更大注意力偏差和更大的前额叶激活构成了依赖的候选神经认知标志物。兴奋剂依赖强迫性的个体差异对注意力偏差、其脑功能表现及其受多巴胺能刺激的短期调节有显著影响。